Although functional studies indicate that FGF21 counteracts metabolic derangement, increased circulating levels of FGF21 were observed in subjects with obesity and metabolic syndrome [16] prompting the need for more investigations to understand the physiological role of FGF21. Here, FGF21 is linked to obesity due to melanocortin 4 receptor deficiency.